NCT02882893View on ClinicalTrials.gov

Efficacy and Safety of DWP450 for the Treatment of Crows Feet Lines

PHASE2/PHASE3UnknownINTERVENTIONAL
Enrollment

238

Participants

Timeline

Start Date

August 31, 2016

Primary Completion Date

January 31, 2017

Study Completion Date

April 30, 2017

Conditions
Crows Feet Lines
Interventions
DRUG

Clostridium Botulinum A Toxin

DRUG

Clostridium Botulinum A Toxin

Trial Locations (1)

Unknown

RECRUITING

Konkuk University Medical Center, Seoul

Sponsors
All Listed Sponsors
lead

Daewoong Pharmaceutical Co. LTD.

INDUSTRY

NCT02882893 - Efficacy and Safety of DWP450 for the Treatment of Crows Feet Lines | Biotech Hunter | Biotech Hunter